Bone marrow-derived cells for cardiovascular cell therapy: an optimized GMP method based on low-density gradient improves cell purity and function

BACKGROUND: Cardiovascular cell therapy represents a promising field, with several approaches currently being tested. The advanced therapy medicinal product (ATMP) for the ongoing METHOD clinical study (“Bone marrow derived cell therapy in the stable phase of chronic ischemic heart disease”) consist...

Descripción completa

Detalles Bibliográficos
Autores principales: Radrizzani, Marina, Lo Cicero, Viviana, Soncin, Sabrina, Bolis, Sara, Sürder, Daniel, Torre, Tiziano, Siclari, Francesco, Moccetti, Tiziano, Vassalli, Giuseppe, Turchetto, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189603/
https://www.ncbi.nlm.nih.gov/pubmed/25260977
http://dx.doi.org/10.1186/s12967-014-0276-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189603/
https://www.ncbi.nlm.nih.gov/pubmed/25260977
http://dx.doi.org/10.1186/s12967-014-0276-0

Ejemplares similares